Skip to main content
SpringerLink
Log in

Improving Prognosis for Kidney Disorders

  • Book
  • © 2002

Overview

Editors:
  1. Morrell Michael Avram

    1. Long Island College Hospital, Brooklyn, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (15 chapters)

  1. Front Matter

    Pages i-xv
    Download chapter PDF

  2. How to Achieve Maximal Renoprotection in Non-Diabetic Chronic Renal Disease

    • Maarten W. Taal, Barry M. Brenner
    Pages 1-8

  3. Anemia of Chronic Kidney Disease and its Management with Recombinant Human Erythropoietin and Darbepoetin Alfa

    • Allen R. Nissenson, Eric M. Tong
    Pages 9-27

  4. Cardiovascular Disease in Patients with Chronic Kidney Disease: The Causes and Effects

    • Adeera Levin, Ognjenka Djurdjev, Brendan Barrett, Ellen Burgess, Euan Carlisle, Jean Ethier et al.
    Pages 29-38

  5. Metabolic Pathogenesis of Cardio-Renal Disease

    • William F. Keane
    Pages 39-43

  6. Oxidative Stress and Inflammation in Hemodialysis Patients

    • Margaret Spittle, Nicholas A. Hoenich, Garry Handelman, Rohini Adhikarla, Peter Homel, Nathan W. Levin
    Pages 45-52

  7. Prognostic Value of Enrollment Parathyroid Hormone in Hemodialysis and Peritoneal Dialysis Patients for Survival. A 14 years Follow-up

    • Morrell Michael Avram, Neal Mittman, Maung M. Myint, Paul Fein
    Pages 53-59

  8. Prealbumin As an Important Predictor for Survival and Nutritional Status in Hemodialysis and Peritoneal Dialysis Patients

    • Neal Mittman, Morrell Michael Avram, Kyin K. Oo, Jyoti Chattopadhyay
    Pages 61-67

  9. How to Attain Optimal Antiproteinuric Dose of Losartan in Non-Diabetic Patients with Nephrotic Range Proteinuria

    • Gozewijn D. Laverman, Robert H. Henning, Paul E. de Jong, Gerjan Navis, Dick de Zeeuw
    Pages 69-73

  10. Hypoalbuminemia in the Patient with Renal Disease: Its Causes and Consequences

    • George A. Kaysen
    Pages 75-89

  11. Kidney Disease and Mechanisms that Cause Loss of Muscle Mass

    • William E. Mitch, S. Russ Price
    Pages 91-96

  12. Role of Plasma Homocysteine and Plasminogen Activator Inhibitor-1 in the Progression of Diabetic Nephropathy

    • Peter Hovind, Lise Tarnow, Peter Rossing, Coen D. A. Stehouwer, Jef J. Emeis, Hans-Henrik Parving
    Pages 97-101

  13. Effects of Erythropoietin(EPO)and Aminoguanidine (AG) on Deformability (df) in Diabetic Azotemic and Uremic Patients

    • Clinton D. Brown, Zhong H. Zhao, Lorraine L. Thomas, R. deGroof, Eli A. Friedman
    Pages 103-108

  14. Characterization of the PKD 1 Gene Product, Polycystin-1

    • Alessandra Boletta, Feng Qian, Luiz F. Onuchic, Alessandra Bragonzi, Marina Cortese, Pierre J. Courtoy et al.
    Pages 109-118

  15. Nutrition and Blood Pressure

    • Joel D. Kopple
    Pages 119-123

  16. How to Minimize Bone Disease in Renal Failure

    • Kevin J. Martin, Esther A. González
    Pages 125-131

  17. Back Matter

    Pages 133-134
    Download chapter PDF
Back to top

Keywords

About this book

More than half a million people worldwide are now sustained by renal replacement therapy, mainly hemodialysis at a cost exceeding USD 30 billion per year. Each case of ESRD that is delayed or prevented saves funds that may be applied to other aspects of health care. Edited by an internationally renowned nephrologist, Prognosis for Kidney Disorders provides a timely summary of exciting work in progress directed toward renoprotection and of ultimate interdiction of ESRD.
Suitable for researchers and clinicians, Dr. Morrell Michael Avram has collected and commented on promising initiatives likely to enter everyday practice in the immediate future. Suitable for renal trainees, experienced kidney doctors, nurses, nutritionists and cardiologists.

Editors and Affiliations

  • Long Island College Hospital, Brooklyn, USA

    Morrell Michael Avram

Bibliographic Information

  • Book Title: Improving Prognosis for Kidney Disorders

  • Editors: Morrell Michael Avram

  • DOI: https://doi.org/10.1007/978-94-017-1848-6

  • Publisher: Springer Dordrecht

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media Dordrecht 2002

  • Hardcover ISBN: 978-1-4020-0995-2Published: 31 October 2002

  • Softcover ISBN: 978-90-481-6164-5Published: 08 December 2010

  • eBook ISBN: 978-94-017-1848-6Published: 29 June 2013

  • Edition Number: 1

  • Number of Pages: XVI, 134

  • Topics: Nephrology, Cardiology, Public Health, Internal Medicine, General Practice / Family Medicine

Publish with us

Policies and ethics

Back to top

Search

Navigation